Status:
ACTIVE_NOT_RECRUITING
Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
Lead Sponsor:
Celltrion
Conditions:
Healthy Participants
Eligibility:
All Genders
19-55 years
Phase:
PHASE1
Brief Summary
This study is designed to demonstrate PK similarity of the proposed biosimilar test product CT-P52 and the reference product, US-licensed Taltz.
Eligibility Criteria
Inclusion
- Healthy male or female subjects between the ages of 19 to 55 years, both inclusive.
- Subject with a body weight of ≥60 and ≤90 kg for male and ≥50 and ≤90 kg for female, and a BMI between 18.0 and 29.9 kg/m2 (both inclusive) when rounded to the nearest tenth.
- Subject is able to understand and to comply with protocol requirements, instructions, and restrictions.
Exclusion
- A medical history and/or condition that is considered significant
- Clinically significant allergic reactions, hypersensitivity
- History or current infection of human immunodeficiency virus, hepatitis B virus, hepatitis C virus or syphilis
- Active or latent Tuberculosis
- Previous monoclonal antibody or fusion protein treatment, or current use of any biologics
- Plans to donate whole blood or blood components during the study
- Male subject who is planning to have child or donate sperms within 10 weeks after the study drug administration. Female subject who is currently pregnant or lactating, or planning to be pregnant or to breastfeed within 10 weeks after the administration of the study drug
- Reasonable evidence or history of drug/alcohol/smoking abuse
- Presence of tattoos, sunburn, or other skin disturbances on the injection site
- Vulnerable subject
Key Trial Info
Start Date :
September 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT07200986
Start Date
September 17 2025
End Date
March 31 2026
Last Update
December 31 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje University Busan Paik Hospital
Busan, Busanjin-gu, South Korea
2
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, South Korea
3
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
4
Chungbuk National University Hospital
Cheongju-si, North Chungcheong, South Korea